Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Park Hotels & Resorts
PK
$3.07B
| $3.27M | ﹤0.01% |
264,602
-85,558
| -24% | -$1.12M |
|
1802
Primerica
PRI
$10.1B
| $3.27M | ﹤0.01% |
18,976
+14,008
| +282% | +$2.3M |
|
|
IMGN
1803
DELISTED
Immunogen Inc
IMGN
| $3.27M | ﹤0.01% |
850,735
+70,086
| +9% | +$299K |
|
|
HTLF
1804
DELISTED
Heartland Financial USA, Inc.
HTLF
| $3.26M | ﹤0.01% |
85,078
+18,925
| +29% | +$868K |
|
1805
Empire State Realty Trust
ESRT
$886M
| $3.26M | ﹤0.01% |
502,356
-13,316
| -3% | -$97.5K |
|
|
AAIC
1806
DELISTED
Arlington Asset Investment Corp.
AAIC
| $3.26M | ﹤0.01% |
1,139,856
-266,582
| -19% | -$785K |
|
1807
US Foods
USFD
$22.2B
| $3.26M | ﹤0.01% |
88,171
-148,144
| -63% | -$5.49M |
|
1808
Veracyte
VCYT
$3.73B
| $3.25M | ﹤0.01% |
145,703
-29,896
| -17% | -$723K |
|
1809
Novavax
NVAX
$1.22B
| $3.24M | ﹤0.01% |
467,948
+481
| +0.1% | +$4.42K |
|
1810
VanEck Junior Gold Miners ETF
GDXJ
$6.88B
| $3.24M | ﹤0.01% |
82,020
-95,375
| -54% | -$3.52M |
|
1811
Timken Company
TKR
$9.74B
| $3.22M | ﹤0.01% |
39,392
-9,742
| -20% | -$788K |
|
|
BDN
1812
Brandywine Realty Trust
BDN
$543M
| $3.22M | ﹤0.01% |
680,395
-129,986
| -16% | -$763K |
|
1813
EastGroup Properties
EGP
$11.3B
| $3.22M | ﹤0.01% |
19,457
-14,641
| -43% | -$2.38M |
|
|
CPRX
1814
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.21M | ﹤0.01% |
193,839
-97,614
| -33% | -$1.61M |
|
1815
Chegg
CHGG
$110M
| $3.21M | ﹤0.01% |
197,018
-139,706
| -41% | -$2.61M |
|
1816
Revolution Medicines
RVMD
$38.7B
| $3.2M | ﹤0.01% |
147,949
+5,950
| +4% | +$147K |
|
1817
Thor Industries
THO
$4.07B
| $3.2M | ﹤0.01% |
40,223
+8,630
| +27% | +$761K |
|
1818
Relay Therapeutics
RLAY
$4.02B
| $3.2M | ﹤0.01% |
194,470
-77,369
| -28% | -$1.39M |
|
1819
Advanced Energy
AEIS
$11.5B
| $3.2M | ﹤0.01% |
32,641
+14,508
| +80% | +$1.37M |
|
1820
Liberty Global Class C
LBTYK
$3.61B
| $3.2M | ﹤0.01% |
156,837
-50,362
| -24% | -$1.06M |
|
1821
Radian Group
RDN
$5.28B
| $3.19M | ﹤0.01% |
144,416
-9,456
| -6% | -$201K |
|
|
KYNB
1822
Kyntra Bio
KYNB
$27.3M
| $3.18M | ﹤0.01% |
6,827
-1,273
| -16% | -$674K |
|
1823
Fox Factory Holding Corp
FOXF
$800M
| $3.18M | ﹤0.01% |
26,239
+9,439
| +56% | +$1.08M |
|
1824
Evercore
EVR
$12.2B
| $3.18M | ﹤0.01% |
27,600
-1,121
| -4% | -$139K |
|
1825
Cable One
CABO
$244M
| $3.18M | ﹤0.01% |
4,534
+83
| +2% | +$60.4K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.